Literature DB >> 12198363

A review of methadone deaths in Jefferson County, Alabama.

Irina Mikolaenko1, C Andrew Robinson, Gregory G Davis.   

Abstract

Interpretation of the concentration of a drug is more difficult when a combination of drugs is present in a decedent's blood. An increase in deaths resulting from co-intoxication with methadone and a benzodiazepine led the authors to perform a retrospective study of cases examined at the Jefferson County Coroner/Medical Examiner Office. They found 101 deaths wherein methadone was detected in the blood. Based on the drugs detected in the blood, these 101 cases were grouped into four categories: (1) pure methadone intoxication, (2) intoxication with methadone and benzodiazepine, (3) intoxication with methadone and other drugs excluding benzodiazepine, and (4) intoxication with methadone, benzodiazepines, and other drugs. Methadone was the sole intoxicant in 15 cases, with a mean concentration of 0.27 mg/L. Benzodiazepines were the most frequently detected co-intoxicant (60 of 101 cases). Benzodiazepine was the only co-intoxicant in 30 cases, and the mean methadone concentration in those 30 cases was 0.599 mg/L. Higher levels of methadone may occur in acute intoxication with methadone and benzodiazepine because benzodiazepines compete with methadone for methadone receptors. Higher levels of methadone may occur with chronic abuse of methadone and benzodiazepines because over time, benzodiazepines inhibit the hepatic enzymes that metabolize methadone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198363     DOI: 10.1097/00000433-200209000-00021

Source DB:  PubMed          Journal:  Am J Forensic Med Pathol        ISSN: 0195-7910            Impact factor:   0.921


  10 in total

1.  Perceived stress and substance use in methadone-maintained smokers.

Authors:  Ethan Moitra; Bradley J Anderson; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2013-08-26       Impact factor: 4.492

2.  The source of methadone in overdose deaths in Western Virginia in 2004.

Authors:  Melissa B Weimer; P Todd Korthuis; George S Behonick; Martha J Wunsch
Journal:  J Addict Med       Date:  2011-09       Impact factor: 3.702

3.  Clinical characteristics of central European and North American samples of pregnant women screened for opioid agonist treatment.

Authors:  A S Unger; P R Martin; K Kaltenbach; S M Stine; S H Heil; H E Jones; A M Arria; M G Coyle; P Selby; G Fischer
Journal:  Eur Addict Res       Date:  2010-02-17       Impact factor: 3.015

4.  Staff attitudes and the associations with treatment organisation, clinical practices and outcomes in opioid maintenance treatment.

Authors:  Linn Gjersing; Helge Waal; John R M Caplehorn; Michael Gossop; Thomas Clausen
Journal:  BMC Health Serv Res       Date:  2010-07-06       Impact factor: 2.655

5.  Parent and Metabolite Opioid Drug Concentrations in Unintentional Deaths Involving Opioid and Benzodiazepine Combinations.

Authors:  Marcia D Fields; Marie A Abate; Lan Hu; D Leann Long; Matthew L Blommel; Nabila A Haikal; James C Kraner
Journal:  J Forensic Sci       Date:  2015-07       Impact factor: 1.832

Review 6.  Methadone: a new old drug with promises and pitfalls.

Authors:  Jodie A Trafton; Abhinav Ramani
Journal:  Curr Pain Headache Rep       Date:  2009-02

Review 7.  Polydrug abuse: a review of opioid and benzodiazepine combination use.

Authors:  Jermaine D Jones; Shanthi Mogali; Sandra D Comer
Journal:  Drug Alcohol Depend       Date:  2012-08-02       Impact factor: 4.492

8.  The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario.

Authors:  Alexandra M Franklyn; Joseph K Eibl; Graham Gauthier; David Pellegrini; Nancy E Lightfoot; David C Marsh
Journal:  Harm Reduct J       Date:  2017-01-26

9.  The Role of Risk or Contributory Death Factors in Methadone-Related Fatalities: A Review and Pooled Analysis.

Authors:  Arianna Giorgetti; Jennifer Pascali; Massimo Montisci; Irene Amico; Barbara Bonvicini; Paolo Fais; Alessia Viero; Raffaele Giorgetti; Giovanni Cecchetto; Guido Viel
Journal:  Metabolites       Date:  2021-03-22

10.  Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993-2014.

Authors:  Matthew E Hirschtritt; Kevin L Delucchi; Mark Olfson
Journal:  Prev Med Rep       Date:  2017-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.